These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5320454)

  • 61. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.
    COATNEY GR; CONTACOS PG; LUNN JS
    Am J Trop Med Hyg; 1964 May; 13():383-5. PubMed ID: 14159973
    [No Abstract]   [Full Text] [Related]  

  • 62. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 63. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 64. THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST FALCIPARUM MALARIA.
    CONTACOS PG; COATNEY GR; LUNN JS; KILPATRICK JW
    Am J Trop Med Hyg; 1964 May; 13():386-90. PubMed ID: 14159974
    [No Abstract]   [Full Text] [Related]  

  • 65. A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea.
    Rieckmann KH
    Am J Trop Med Hyg; 1966 Nov; 15(6):833-7. PubMed ID: 5335161
    [No Abstract]   [Full Text] [Related]  

  • 66. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.
    COATNEY GR; CONTACOS PG; LUNN JS; KILPATRICK JW; ELDER HA
    Am J Trop Med Hyg; 1963 Jul; 12():504-8. PubMed ID: 14044760
    [No Abstract]   [Full Text] [Related]  

  • 67. Preliminary evaluation of cycloguanil pamoate in dermal leishmaniasis.
    Peña Chavarría A; Kotcher E; Lizano C
    JAMA; 1965 Dec; 194(10):1142-4. PubMed ID: 5897797
    [No Abstract]   [Full Text] [Related]  

  • 68. A sensitive bioassay for serum cycloguanil using Plasmodium falciparum in vitro.
    Scott HV; Edstein MD; Veenendaal JR; Rieckmann KH
    Int J Parasitol; 1988 Jul; 18(5):605-9. PubMed ID: 3049411
    [No Abstract]   [Full Text] [Related]  

  • 69. Acquired resistance to proguanil in Plasmodium vivax.
    SEATON DR; LOURIE EM
    Lancet; 1949 Mar; 1(6549):394. PubMed ID: 18112625
    [No Abstract]   [Full Text] [Related]  

  • 70. A study among African school-children of the repository antimalarial properties of cycloguanil pamoate, 4,4+-diacetyldiaminodiphenylsulfone, and a combination of the two drugs.
    Laing AB; Pringle G; Lane FC
    Am J Trop Med Hyg; 1966 Nov; 15(6):838-48. PubMed ID: 5335427
    [No Abstract]   [Full Text] [Related]  

  • 71. Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa.
    McGregor IA; Williams K; Walker GH; Rahman AK
    Br Med J; 1966 Mar; 1(5489):695-701. PubMed ID: 5909480
    [No Abstract]   [Full Text] [Related]  

  • 72. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide.
    SCHMIDT LH; LOO TL; FRADKIN R; HUGHES HB
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):367-70. PubMed ID: 14949053
    [No Abstract]   [Full Text] [Related]  

  • 73. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH; Rossan RN
    Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.
    Murphy JR; Baqar S; Davis JR; Herrington DA; Clyde DF
    J Clin Microbiol; 1989 Jul; 27(7):1434-7. PubMed ID: 2671011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 76. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 78. Antimalarial drug resistance: an increasing problem.
    Peters W
    Br Med Bull; 1982 May; 38(2):187-92. PubMed ID: 7052200
    [No Abstract]   [Full Text] [Related]  

  • 79. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.